Literature DB >> 21047773

Roles of fibroblast growth factor receptors in carcinogenesis.

Ellen Margrethe Haugsten1, Antoni Wiedlocha, Sjur Olsnes, Jørgen Wesche.   

Abstract

The fibroblast growth factor receptors (FGFR) play essential roles both during development and in the adult. Upon ligand binding, FGFRs induce intracellular signaling networks that tightly regulate key biological processes, such as cell proliferation, survival, migration, and differentiation. Deregulation of FGFR signaling can thus alter tissue homeostasis and has been associated with several developmental syndromes as well as with many types of cancer. In human cancer, FGFRs have been found to be deregulated by multiple mechanisms, including aberrant expression, mutations, chromosomal rearrangements, and amplifications. In this review, we will give an overview of the main FGFR alterations described in human cancer to date and discuss their contribution to cancer progression. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047773     DOI: 10.1158/1541-7786.MCR-10-0168

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  103 in total

Review 1.  Genetic changes in squamous cell lung cancer: a review.

Authors:  Rebecca S Heist; Lecia V Sequist; Jeffrey A Engelman
Journal:  J Thorac Oncol       Date:  2012-05       Impact factor: 15.609

2.  Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

Authors:  Laëtitia Comps-Agrar; Diana Ronai Dunshee; Dan L Eaton; Junichiro Sonoda
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

3.  Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.

Authors:  Marianne E Marshall; Trista K Hinz; Scott A Kono; Katherine R Singleton; Brady Bichon; Kathryn E Ware; Lindsay Marek; Barbara A Frederick; David Raben; Lynn E Heasley
Journal:  Clin Cancer Res       Date:  2011-06-14       Impact factor: 12.531

4.  Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.

Authors:  Nobuhiro Ueno; Akio Shimizu; Michiyuki Kanai; Yugo Iwaya; Shugo Ueda; Jun Nakayama; Misuzu Kurokawa Seo
Journal:  J Histochem Cytochem       Date:  2015-10-20       Impact factor: 2.479

5.  RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR.

Authors:  Agata M Trzcińska-Daneluti; Anthony Chen; Leo Nguyen; Ryan Murchie; Chong Jiang; Jason Moffat; Lawrence Pelletier; Daniela Rotin
Journal:  Mol Cell Proteomics       Date:  2015-03-29       Impact factor: 5.911

6.  FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

Authors:  Joshua Z Drago; Luigi Formisano; Carlos L Arteaga; Aditya Bardia; Dejan Juric; Andrzej Niemierko; Alberto Servetto; Seth A Wander; Laura M Spring; Neelima Vidula; Jerry Younger; Jeffrey Peppercorn; Megan Yuen; Giuliana Malvarosa; Dennis Sgroi; Steven J Isakoff; Beverly Moy; Leif W Ellisen; A John Iafrate
Journal:  Clin Cancer Res       Date:  2019-08-01       Impact factor: 12.531

7.  A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma.

Authors:  Rekha Gyanchandani; Marcus V Ortega Alves; Jeffrey N Myers; Seungwon Kim
Journal:  Mol Cancer Res       Date:  2013-10-03       Impact factor: 5.852

8.  Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.

Authors:  Anat Globerson-Levin; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

9.  FGFR1 amplification in squamous cell carcinoma of the lung.

Authors:  Rebecca S Heist; Mari Mino-Kenudson; Lecia V Sequist; Swathi Tammireddy; Laura Morrissey; David C Christiani; Jeffrey A Engelman; A John Iafrate
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

10.  Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.

Authors:  Michal Kostas; Ellen Margrethe Haugsten; Yan Zhen; Vigdis Sørensen; Patrycja Szybowska; Elisa Fiorito; Susanne Lorenz; Nina Jones; Gustavo Antonio de Souza; Antoni Wiedlocha; Jørgen Wesche
Journal:  Mol Cell Proteomics       Date:  2018-01-25       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.